Through more than 60 intuitive tables and charts, you will receive unique insights into high-level trends and significant developments, and can easily drill down to details of a specific product or therapeutic area.
Need to know when Drug X will expire? Expiration dates for reference products draw on analysis of products, active agents, and manufacturing processes to go far beyond the Orange Book.
Need to know who is developing biobetters for interferons? Access a complete list with generic and candidate names, developers, reference products, and earliest possible EU/US launch dates.
The report's author has also included concise commentary throughout, providing valuable context and key insights.
For a complete guide to biosimilars at your fingertips, download Charting the Biosimilar and Biobetter Development Pipeline today.
Key Report Features
More than 60 exclusive tables and charts, offering a complete and illuminating view of the biosimilar pipeline
Up-to-the-minute details of ALL biosimilars/biobetters known to be in development in US and EU markets, with their development status and earliest potential launch dates
Information on international biogenerics that may seek approval as biosimilars/biobetters in US and EU markets
Comprehensive list of reference products, with key sales data and expected patent expiration dates
Detailed analysis of the biosimilar pipeline and market by reference products, therapeutic area, drug class, and compound class
Reports showing the most active companies, regions, and countries
Insights into areas of most intense competition
Copyright©2012 PR Newswire.
All rights reserved